![cover image](https://wikiwandv2-19431.kxcdn.com/_next/image?url=https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Sevelamer.png/640px-Sevelamer.png&w=640&q=50)
Sevelamer
Chemical compound / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Renagel?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Sevelamer (rINN) is a phosphate binding medication used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is marketed by Sanofi under the brand names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate).
Quick Facts Clinical data, Pronunciation ...
![]() | |
Clinical data | |
---|---|
Pronunciation | (/sɛˈvɛləmər/ or /sɛˈvɛləmɪər/) |
Trade names | Renagel, Renvela |
AHFS/Drugs.com | Monograph |
MedlinePlus | a601248 |
License data | |
Pregnancy category |
|
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 0% |
Excretion | Feces 100% |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | [(C3H7N)a+b.(C9H17N2O)c]m where a+b:c = 9:1 |
Molar mass | variable |
![]() ![]() |
Close